MARUHO CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1918-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.maruho.co.jp
Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-11-04
- Last Posted Date
- 2017-08-03
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT02596074
- Locations
- 🇳🇱
LUMC/Centre for Human Drug Research, Leiden, Netherlands
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 263
- Registration Number
- NCT02576860
Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2022-07-19
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 307
- Registration Number
- NCT02576847
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-10-08
- Last Posted Date
- 2017-03-27
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 320
- Registration Number
- NCT02571998
Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2022-08-02
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 463
- Registration Number
- NCT02547441
Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis
- First Posted Date
- 2015-05-28
- Last Posted Date
- 2016-07-28
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 37
- Registration Number
- NCT02456480
- Locations
- 🇳🇱
Centre for Human Drug Research, Zernikedreef 8, Netherlands
A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-01-07
- Last Posted Date
- 2016-07-28
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT02333643
- Locations
- 🇳🇱
LUMC/Centre for Human Drug Research, Leiden, Netherlands
Open-label Study of ASP2151 in Herpes Simplex Patients
- First Posted Date
- 2014-08-05
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 250
- Registration Number
- NCT02209324
- Locations
- 🇯🇵
Oota-ku Tokyo Japan, Tokyo, Japan
🇯🇵Sapporo Hokkaido Japan, Sapporo, Japan
🇯🇵Yokohama Kanagawa Japan, Yokohama, Japan
First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts
- First Posted Date
- 2014-04-08
- Last Posted Date
- 2014-05-23
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT02106260
- Locations
- 🇳🇱
Centre for Human Drug Research, Zernikedreef 8, Netherlands
Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2014-02-19
- Last Posted Date
- 2015-09-17
- Lead Sponsor
- Maruho Co., Ltd.
- Target Recruit Count
- 327
- Registration Number
- NCT02066545
- Locations
- 🇺🇸
Skin Surgery Medical Group, Inc., San Diego, California, United States
🇺🇸Skin Care Research, Inc., Boca Raton, Florida, United States
🇺🇸Moore Clinical Research, Inc., Tampa, Florida, United States
© Copyright 2024. All Rights Reserved by MedPath